CLASS-II-ANTIGEN-NEGATIVE PATIENT AND MUTANT B-CELL LINES REPRESENT AT LEAST 3, AND PROBABLY 4, DISTINCT GENETIC-DEFECTS DEFINED BY COMPLEMENTATION ANALYSIS

被引:130
作者
BENICHOU, B
STROMINGER, JL
机构
[1] Dept. of Biochem. and Molec. Biology, Harvard University, Cambridge
关键词
D O I
10.1073/pnas.88.10.4285
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Expression of class II major histocompatibility complex antigens in defective B-lymphoblastoid cell lines from patients with class II antigen deficiency and from in vitro mutants generated with the same phenotype was studied. By heterogenetic fusion experiments, at least three, and probably four, complementation groups were defined. Furthermore, clone 13 (a DR-, DP-, but DQ+ cell line) appeared to belong to the RJ2.2.5 complementation group, for which all other members are DR-, DP-, and also DQ-. Thus, it is hypothesized that the cell lines of this group lack the activity of a gene that can differentially regulate the DR/DP and the DQ promoters.
引用
收藏
页码:4285 / 4288
页数:4
相关论文
共 38 条
[2]   TRANS-ACTING ELEMENT(S) OPERATING ACROSS SPECIES BARRIERS POSITIVELY REGULATE EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENES [J].
ACCOLLA, RS ;
SCARPELLINO, L ;
CARRA, G ;
GUARDIOLA, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (04) :1117-1133
[3]   REACTIVATION BY A TRANS-ACTING FACTOR OF HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX IA GENE-EXPRESSION IN INTERSPECIES HYBRIDS BETWEEN AN IA-NEGATIVE HUMAN B-CELL VARIANT AND AN IA-POSITIVE MOUSE B-CELL LYMPHOMA [J].
ACCOLLA, RS ;
CARRA, G ;
GUARDIOLA, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (15) :5145-5149
[4]   RAPID REPROGRAMMING OF GLOBIN GENE-EXPRESSION IN TRANSIENT HETEROKARYONS [J].
BARON, MH ;
MANIATIS, T .
CELL, 1986, 46 (04) :591-602
[5]   ROLE OF MHC GENE-PRODUCTS IN IMMUNE REGULATION [J].
BENACERRAF, B .
SCIENCE, 1981, 212 (4500) :1229-1238
[6]  
BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.iy.08.040190.003341
[7]   EVIDENCE FOR A TRANS-ACTING FACTOR THAT REGULATES THE TRANSCRIPTION OF CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX GENES - GENETIC AND FUNCTIONAL-ANALYSIS [J].
CALMAN, AF ;
PETERLIN, BM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :8830-8834
[8]  
CALMAN AF, 1987, J IMMUNOL, V139, P2489
[9]   SUCCESSFUL TREATMENT WITH AN UNRELATED-DONOR BONE-MARROW TRANSPLANT IN AN HLA-DEFICIENT PATIENT WITH SEVERE COMBINED IMMUNE-DEFICIENCY (BARE LYMPHOCYTE SYNDROME) [J].
CASPER, JT ;
ASH, RA ;
KIRCHNER, P ;
HUNTER, JB ;
HAVENS, PL ;
CHUSID, MJ .
JOURNAL OF PEDIATRICS, 1990, 116 (02) :262-265
[10]   BARE LYMPHOCYTE SYNDROME - CONSEQUENCES OF ABSENT CLASS-II MAJOR HISTOCOMPATIBILITY ANTIGEN EXPRESSION FOR LYMPHOCYTE-B DIFFERENTIATION AND FUNCTION [J].
CLEMENT, LT ;
PLAEGERMARSHALL, S ;
HAAS, A ;
SAXON, A ;
MARTIN, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (03) :669-675